Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/2645
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kasaplar, Pınar | - |
dc.contributor.author | Çakmak, Özgür Yılmazer | - |
dc.contributor.author | Çağır, Ali | - |
dc.date.accessioned | 2016-12-21T13:06:23Z | - |
dc.date.available | 2016-12-21T13:06:23Z | - |
dc.date.issued | 2010-10 | - |
dc.identifier.citation | Kasaplar, P., Çakmak, Ö. Y., and Çağır, A. (2010). Michael acceptor properties of 6-bicycloaryl substituted (R)-5,6-dihydro-2H-pyran-2-ones. Bioorganic Chemistry, 38(5), 186-189. doi:10.1016/j.bioorg.2010.06.005 | en_US |
dc.identifier.issn | 0045-2068 | - |
dc.identifier.uri | http://doi.org/10.1016/j.bioorg.2010.06.005 | - |
dc.identifier.uri | http://hdl.handle.net/11147/2645 | - |
dc.description.abstract | The mechanism of action for α,β-unsaturated lactones can be explained by their Michael acceptor properties. They have the potential of being covalently binding inhibitors by accepting nucleophiles from target proteins. In this work, Michael addition reactions of ethanethiol with 6-bicycloaryl substituted 5,6-dihydro-2H-pyran-2-ones were studied to explore the existence of such interactions. Three of the Michael addition products were isolated and tested over PC3 (human prostate cancer) and MCF-7 (human breast adenocarcinoma) cancer cell lines and no cytotoxicity was observed. It was revealed that biological activity depends on the existence of a Michael acceptor, but potency probably depends upon the 3D structure of the substituent on lactone ring. The primary chemical-quantum properties of the lactones were also calculated using the Spartan'08 computer program. © 2010 Elsevier Inc. All rights reserved. | en_US |
dc.description.sponsorship | TÜBİTAK-TBAG Research Grant 105T429 | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Ltd. | en_US |
dc.relation.ispartof | Bioorganic Chemistry | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Michael addition | en_US |
dc.subject | Antineoplastic agent | en_US |
dc.subject | (R)-goniothalamin | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Log P | en_US |
dc.title | Michael acceptor properties of 6-bicycloaryl substituted (R)-5,6-dihydro-2H-pyran-2-ones | en_US |
dc.type | Article | en_US |
dc.authorid | TR110975 | en_US |
dc.institutionauthor | Çakmak, Özgür Yılmazer | - |
dc.institutionauthor | Çağır, Ali | - |
dc.department | İzmir Institute of Technology. Chemistry | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.startpage | 186 | en_US |
dc.identifier.endpage | 189 | en_US |
dc.identifier.wos | WOS:000285403000008 | en_US |
dc.identifier.scopus | 2-s2.0-77955556352 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.1016/j.bioorg.2010.06.005 | - |
dc.identifier.pmid | 20655568 | en_US |
dc.relation.doi | 10.1016/j.bioorg.2010.06.005 | en_US |
dc.coverage.doi | 10.1016/j.bioorg.2010.06.005 | en_US |
dc.identifier.wosquality | Q1 | - |
dc.identifier.scopusquality | Q1 | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Article | - |
crisitem.author.dept | 04.01. Department of Chemistry | - |
Appears in Collections: | Chemistry / Kimya PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
8
checked on Nov 15, 2024
WEB OF SCIENCETM
Citations
8
checked on Oct 26, 2024
Page view(s)
596
checked on Nov 18, 2024
Download(s)
332
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.